Journal
BIOLOGICAL REVIEWS
Volume 95, Issue 1, Pages 232-243Publisher
WILEY
DOI: 10.1111/brv.12561
Keywords
sortilin; lipid metabolism; atherogenesis; hepatocyte; adipocyte; macrophage
Categories
Funding
- National Natural Science Foundation of China [81870336, 81670426] Funding Source: Medline
Ask authors/readers for more resources
Dyslipidemia, including increased plasma levels of low-density lipoprotein cholesterol (LDL-C), very low-density lipoprotein cholesterol and triglyceride, and decreased plasma levels of high-density lipoprotein cholesterol, has been considered a key factor associated with a series of health problems grouped together as metabolic syndrome. Worldwide, dyslipidemia has become a pressing issue, together with the rising prevalence of metabolic syndrome and cardiovascular disease (CVD). Recently, multiple genome-wide association studies and experimental analyses have been used to assess the underlying genetic basis of lipid metabolism and to identify novel gene loci that contribute to the alterations in lipid levels. The results have demonstrated that sortilin, which is encoded by SORT1, plays an important role in modulating the level of LDL-C and the risk of CVD. Herein, we summarize the current understanding of the role of sortilin in the pathogenesis of dyslipidemia and atherosclerosis. Furthermore, we provide new insights into the potential mechanisms by which sortilin affects lipid metabolism in hepatocytes, adipocytes, and macrophages.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available